Skip to content
10-Q/A

Quarterly Report

Glenfarne Merger Corp.

0001213900-22-005734

← back to feed
Filed
Feb 7, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$1.72M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $897
Cash And Equivalents Q3 2021 · Sep 30, 2021 $915.25K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $7K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $12.9K
Stockholders Equity Q3 2021 · Sep 30, 2021 −$14.2M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$18.91M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$18.78M
Stockholders Equity Q3 2021 · Dec 31, 2020 $16.18K
Stockholders Equity Q3 2021 · Sep 30, 2020 $16.18K
Current Liabilities Q3 2021 · Sep 30, 2021 $368.78K
Current Liabilities Q3 2021 · Dec 31, 2020 $273.43K
Total Liabilities Q3 2021 · Sep 30, 2021 $16.25M
Total Liabilities Q3 2021 · Dec 31, 2020 $273.43K
Current Assets Q3 2021 · Sep 30, 2021 $2.03M
Current Assets Q3 2021 · Dec 31, 2020 $7K
Total Assets Q3 2021 · Sep 30, 2021 $274.59M
Total Assets Q3 2021 · Dec 31, 2020 $289.61K
Sga Expense Q3 2021 · Sep 30, 2021 $229.54K
Sga Expense Q3 2021 · Sep 30, 2021 $663.96K
Sga Expense Q3 2021 · Sep 30, 2020 $1.83K
Net Income Q3 2021 · Sep 30, 2021 $4.71M
Net Income Q3 2021 · Sep 30, 2021 $5.95M
Net Income Q3 2021 · Sep 30, 2020 −$2.92K
Operating Income Q3 2021 · Sep 30, 2021 −$309.41K
Operating Income Q3 2021 · Sep 30, 2021 −$883.8K
Operating Income Q3 2021 · Sep 30, 2020 −$2.92K